News Article | March 1, 2017
OAKLAND, Calif., March 1, 2017 /PRNewswire/ -- After months of method development and validation with SCIEX Corporation, CW Analytical (CWAL), an ISO 17025 accredited Cannabis testing laboratory, today announced they will be reporting up to 55 toxic chemical residues at parts-per-billion...
News Article | February 21, 2017
Dublin, Feb. 21, 2017 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of Jain PharmaBiotech's new report "Therapeutic Drug Monitoring - Technologies, Markets, and Companies" to their offering. This report deals with therapeutic drug monitoring, a multi-disciplinary clinical specialty, aimed at improving patient care by monitoring drug levels in the blood to individually adjust the dose of drugs for improving outcome. TDM is viewed as a component of personalized medicine that interacts with several other disciplines including pharmacokinetics and pharmacogenetics. One chapter is devoted to monitoring of drugs of abuse (DoA). Various technologies used for well-known DoA are described. A section on drug abuse describes methods of detection of performance-enhancing drugs. TDM market is analyzed from 2015 to 2025 according to technologies as well as geographical distribution. Global market for DoA testing was also analyzed from 2016 to 2026 and divided according to the area of application. Unmet needs and strategies for development of markets for TDM are discussed. The report contains profiles of 27 companies involved in developing tests and equipment for drug monitoring along with their collaborations. The text is supplemented with 18 tables, 6 figures and 190 selected references from literature. Benefits of this report: - Up-to-date one-stop information on therapeutic drug monitoring - Description of 27 companies involved with their collaborations in this area - Market analysis 2016-2026/ - Market values in major regions - Strategies for developing markets for therapeutic drug monitoring - A selected bibliography of 190 publications - Text is supplemented by 18 tables and 6 figures Who should read this report? - Biotechnology companies developing assays and equipment for drug monitoring - Reference laboratories providing drug monitoring services - Pharmaceutical companies interested in companion tests for monitoring their drugs - Clinical pharmacologists interested in integrating therapeutic drug monitoring with pharmacogenetics for development of personalized medicine Key Topics Covered: Executive Summary 1. Introduction Definitions Historical Landmarks in the development of TDM Pharmacology relevant to TDM Pharmacokinetics Pharmacodynamics Pharmacogenetics Pharmacogenomics Pharmacoproteomics Drug receptors Protein binding Therapeutic range of a drug Variables that affect TDM Indications for TDM Multidisciplinary nature of TDM 2. Technologies for TDM Introduction Sample preparation Proteomic technologies Mass spectrometry Liquid chromatography MS Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Combining capillary electrophoresis with MS Gas-liquid chromatography Tissue imaging mass spectrometry New trends in sample preparation Pressure Cycling Technology Desorption electrospray ionization imaging High Performance Liquid Chromatography (HPLC) Ultra performance LC TDM using dry blood spots Analysis of dried blood spots for drugs using DESI Quantitative analysis of drugs in dried blood spot by paper spray MS Immunoassays Enzyme-linked immunosorbent assay Cloned Enzyme Donor Immunoassay Enzyme Multiplied Immunoassay Technique Fluorescence Polarization Immunoassay Particle Enhanced Turbidimetric Inhibition Immunoassay Radioimmunometric assays Biosensors Nanosensors Biochips & Microarrays Introduction Microchip capillary electrophoresis Phototransistor biochip biosensor Microchip-based fluorescence polarization immunoassay for TDM Cellular microarrays Microfluidics for TDM Lab-on-a-chip Micronics' microfluidic technology Rheonix CARD technology Nano-interface in a microfluidic chip Levitation of nanofluidic drops with physical forces Nanoarrays Nanobiotechology NanoDx Biomarkers Applications of biomarkers in drug safety studies Genomic technologies for toxicology biomarkers Proteomic technologies for toxicology biomarkers Metabonomic technologies for toxicology biomarkers Integration of genomic and metabonomic data to develop toxicity biomarkers Toxicology studies based on biomarkers Biomarkers of hepatotoxicity Biomarkers of nephrotoxicity Cardiotoxicity Neurotoxicity Biomarkers in clinical trials Molecular diagnostics 3. Drug Monitoring Instruments Introduction Description of important instruments AB SCIEX instruments AB SCIEX LC/MS/MS Abbott instruments ARCHITECT c16000 ARCHITECT c4000 ARCHITECT c8000 ARCHITECT ci16200 Integrated System ARCHITECT ci4100 Integrated System ARCHITECT ci8200 integrated with the ARCHITECT i2000SR ARCHITECT i1000SR ARCHITECT i4000SR AxSYM Agilent's 6400 Series Triple Quadrupole LC/MS Alfa Wassermann's ACE Alera AMS Diagnostics' LIASYS Awareness Technology's STAT FAX 4500 Beckman Coulter instruments Beckman Coulter Unicel Series AU5800 automated chemistry systems AU480 Binding Site ESP600 bioMerieux Mini Vidas Carolina BioLis 24i Chromsystems' HPLC instruments Grifols Triturus ABX Pentra 400 Medica EasyRA Nova Biomedical Critical Care Xpress Ortho Clinical Diagnostics' VITROS® family of systems Immunodiagnostic systems Randox intruments Randox RX Imola Roche instruments Cobas® 8000 COBAS INTEGRA® Systems Siemens instruments ADVIA 1200 ADVIA Centaur XP immunoassay system EMIT® II Plus Syva® Viva® Drug Testing Systems Dimension® Xpand® Plus Integrated Chemistry System Thermo Scientific instruments Indiko Tosoh AIA-Series 4. Applications of TDM Introduction Pharmaceutical research and drug development Clinical trials Computerized clinical decision support systems for TDM and dosing Medication-related interferences with measurements of catecholamines Polymorphisms of genes affecting drug metabolism TDM for drug safety TDM in special groups The aged Children Pregnancy TDM of prophylactic therapy Monitoring of vitamin D levels Monitoring of RBC folic acid levels during pregancy Personalized medicine Role of TDM in personalized medicine Applications according to various conditions Anesthesia and critical care Optimizing antimicrobial dosing for critically ill patients TDM monitoring of thiopental continuous infusion in critical care Role of TDM in critical care cardiac patients. Cancer Epilepsy Personalized approach to use of AEDs Infections Virus infections Fungal infections Pain management Role of TDM in pain management Monitoring of analgesic drugs in urine samples AEDs as analgesics Triptans for migraine Psychiatric disorders Guidelines for use of TDM in psychiatric patients TDM of psychotropic drugs Transplantation TDM of Tacrolismus in transplantation TDM of cyclosporine A in transplantation Monitoring of immunosuppression with mycophenolate mofetil Emergency toxicology Future prospects of TDM 5. Drugs Requiring Monitoring Introduction Antiepileptics Carbamazepine TDM of carbamazepine Gabapentin Lacosamide Lamotrigine TDM of lamotrigine Levetiracetam TDM of levetiracetam Phenobarbital TDM of phenobarbital Phenytoin TDM of phenytoin Primidone TDM of primidone Topiramate TDM of topiramate Valproic acid TDM of valproic acid TDM of multiple antiepileptic drugs in plasma/serum Antimicrobials Antibiotics Amikacin Anti-tuberculosis drugs Chloramphenicol Gentamicin Tobramycin Vancomycin Norvancomycin Antiviral agents Anti-HIV drugs Antifungal agents Voriconazole Antidepressants TDM of selective serotonin reuptake inhibitors Antipsychotics Aripiprazole Quetiapine TDM of risperidone TDM of AEDs in psychiatric disorders TDM of multiple drugs in psychiatry Bronchodilators Theophylline Cardiovascular drugs Antiarrhythmic drugs Anticoagulants Dabigatran Antihypertensive drugs ß-blockers Cardiotonic drugs Digoxin TDM of statins for hypercholesterolemia Chemotherapy for cancer TDM of 5-FU TDM of Methotrexate TDM of imitanib Drugs used for treatment of Alzheimer disease Donepezil Galantamine Memantine Drugs used for treatment of Parkinson disease Monitoring of levodopa and carbidopa therapy Catechol-O-methyltransferase inhibitors Drugs for treatment of attention-deficit hyperactivity disorder Atomoxetine Methylphenidate Hypnotic-sedative drugs Benzodiazepines Propofol Immunosuppressive drugs TDM of mycophenolic acid for the treatment of lupus nephritis Steroids Prednisone Miscellaneous drugs Azathioprine Sildenafil 6. Monitoring of Biological Therapies Introduction Cell therapy In vivo tracking of cells Molecular imaging for tracking cells MRI technologies for tracking cells Superparamagnetic iron oxide nanoparticles as MRI contrast agents Visualization of gene expression in vivo by MRI Gene therapy Application of molecular diagnostic methods in gene therapy Use of PCR to study biodistribution of gene therapy vector PCR for verification of the transcription of DNA In situ PCR for direct quantification of gene transfer into cells Detection of retroviruses by reverse transcriptase (RT)-PCR Confirmation of viral vector integration Monitoring of gene expression Monitoring of gene expression by green fluorescent protein Monitoring in vivo gene expression by molecular imaging Monoclonal antibodies Natalizumab 7. Monitoring of Drug Abuse Introduction Tests used for detection of drug abuse Forensic applications of detection of illicit drugs in fingerprints by MALDI MS MS for doping control Randox assays for DoA Drugs of Abuse Array V Urine drug testing TDM of drugs for treatment of substance abuse-related disorders Drug testing to monitor treatment of drug abuse Minimum requirement for drug testing in patients Analgesic abuse ?-blockers as doping agents Detection of ß-blockers in urine Chronic alcohol abuse Cocaine CEDIA for cocaine in human serum Detection of cocaine molecules by nanoparticle-labeled aptasensors Infrared spectroscopy for detection of cocaine in saliva Marijuana Use of marijuana and synthetic cannabinoids Detection of cannabinoids ELISA for detection of synthetic cannabinoids Drug abuse for performance enhancement in sports Historical aspects of drug abuse in sports Drugs used by athletes for performance enhancement Techniques used for detection of drug abuse by athletes Mass spectrometry for detection of peptide hormones miRNAs for the detection of erythropoiesis-stimulating agents Detection of anabolic steroids Body fluids and tissues used for detection of drug abuse in sports Urine drug testing Spray (sweat) drug test kits Hair drug testing Gene doping in sports Gene transfer methods used for enhancing physical performance Misuse of cell therapy in sport Challenges of detecting genetic manipulations in athletes Drug abuse testing in race horses Limitations and future prospects Role of pharmaceutical industry in anti-doping testing 8. Markets for TDM Introduction Methods for market estimation and future forecasts Markets for TDM tests Markets for TDM and DoA testing equipment Geographical distribution of markets for TDM tests Drivers for growth of TDM markets Markets for DoA testing Unmet needs in TDM Cost-benefit studies Simplifying assays and reducing time and cost Strategies for developing markets Physician education Supporting research on TDM Biomarker patents for drug monitoring 9. Companies Profiles of companies Collaborations 10. References For more information about this report visit http://www.researchandmarkets.com/research/g4tq2x/therapeutic_drug
News Article | February 15, 2017
OAK RIDGE, Tenn., Feb. 9, 2017 - Four technologies developed at the Department of Energy's Oak Ridge National Laboratory have earned Federal Laboratory Consortium awards for excellence in technology transfer. The FLC is a network of more than 300 federal laboratories, facilities and research centers dedicated to promoting and strengthening the commercialization of federal laboratory-developed technologies and expertise. The honors place ORNL in elite company, according to Donna Bialozor, FLC Awards committee chair, who wrote: "This year your laboratory is one of a select number of recipients, an indication that your nominations were truly of the highest caliber." Mike Paulus, ORNL's director of technology transfer, noted that it is especially significant that ORNL won four of the 19 FLC awards for excellence in technology transfer. "With these latest awards, ORNL has now won 55 since 1986, reaffirming the importance and relevance of our research and development." ORNL earned recognition for the following technologies: Piranha Text Mining Tool, licensed to Vortex Analytics. Piranha, the recipient of an R&D 100 Award in 2007, is an agent-based technology to analyze text data with unprecedented speed and accuracy. The software suite enables the evaluation of large volumes of unstructured text-based data across many different formats cost effectively and efficiently. The software provides unparalleled processing speeds and is ideal for data mining applications in any situation in which large amounts of text-based data must be analyzed quickly and effectively. Prior to the technology transfer effort that is the subject of this honor, ORNL researchers used the technology in their work with the FBI to mine large amounts of text-based data. Piranha was invented by Thomas Potok, Robert Patton and James Treadwell of ORNL. Others named on the award were David Sims, Marc Filigenzi and Barry Goss. Open Port Sampling Interfaces for Mass Spectrometry, licensed by SCIEX. This innovation dramatically simplifies mass spectrometry, enabling its wider use. Scientists use mass spectrometry to perform chemical analysis with high selectivity and sensitivity, detecting and differentiating millions of chemicals in quantities down to 1 part per billion. The simplicity of the device allows even novices with the means to introduce unprocessed solid or liquid samples into a mass spectrometer without fear of instrument contamination. To identify a compound, researchers simply touch the object of interest to the solvent dome at the sampling end of the probe, which is connected to a mass spectrometer. Almost instantaneously, a screen displays data that identifies the chemical and its approximate concentration. Because this approach requires no sample preparation and the device is self-cleaning, the system is especially attractive for a wide range of applications. The Open Port Sampling Interfaces for Mass Spectrometry technology was invented by Gary Van Berkel and Vilmos Kertesz of ORNL and Tom Covey and Kevin Smith of SCIEX. Also named on the award were Jennifer Caldwell, Edna Gergel and Marc Filligenzi of ORNL. Superhydrophobic Transparent Glass Thin Film Innovation, licensed to Samsung. This transparent glass thin film coating provides glass displays that are extremely water repellant, durable and fingerprint-proof for products such as smart phones and tablets, solar panels, optical components and windows. Unlike more fragile polymeric and powder-based options, this coating exhibits superior resistance to abrasion and is thermally stable to 500 degrees Celsius. The coating uses non-toxic naturally abundant and inexpensive precursor materials. The superhydrophobic coating was invented by ORNL's Tolga Aytug and John Simpson, formerly of ORNL. Also named on the award were Eugene Cochran and Marc Filligenzi of ORNL and Yoon Goo Lee and Debasis Bera of Samsung. Miniature Ion Trap Mass Analyzer, licensed by 908 Devices. This ORNL technology takes mass spectrometry to a new level, making it elegantly simple, easy to use and more affordable. 908 Devices products based on the ORNL technology have demonstrated important public safety benefits in law enforcement and hazardous materials detection. The ORNL technology consists of a highly miniaturized implementation of an ion trap mass analyzer 10 times smaller than conventional scale ion traps. Despite its small size, the device offers the same resolving power as conventional-scale ion trap mass analyzers. The device is also extremely portable. Products that utilize this technology are found in a range of 908 Devices instruments used in more than 18 countries. In addition, 908 Devices is working with the U.S. Army's Next Generation Chemical Detector program to develop devices to detect and identify chemical warfare agents, toxic chemicals and other hazards. The Miniature Ion Trap Mass Analyzer was developed by Michael Ramsey, formerly of ORNL, William Whitten of ORNL, and Kevin Knopp and Christopher Brown, co-founders of 908 Devices. Also named on the award were Jennifer Caldwell, Edna Gergel and Jud Hightower of ORNL. ORNL is managed by UT-Battelle for DOE's Office of Science. DOE's Office of Science is the single largest supporter of basic research in the physical sciences in the United States, and is working to address some of the most pressing challenges of our time. For more information, please visit science.energy.gov. Caption1: Oak Ridge National Laboratory's Open Port Sampling Interfaces for Mass Spectrometry, invented by Gary Van Berkel (left) and Vilmos Kertesz, features simplicity and elegance. Caption 2: The Superhydrophobic Transparent Glass Thin Film Innovation, invented by a team led by Tolga Aytug, provides glass displays that are extremely water repellant, durable and fingerprint-proof for products such as smart phones and tablets, solar panels, optical components and windows. Caption 3: Mike Ramsey, a former researcher at Oak Ridge National Laboratory and co-inventor of the Miniature Ion Trap Mass Analyzer, visited the lab in 2012 to participate in the license signing ceremony with 908 Devices. NOTE TO EDITORS: You may read other press releases from Oak Ridge National Laboratory or learn more about the lab at http://www. . Additional information about ORNL is available at the sites below:
News Article | February 28, 2017
Research and Markets has announced the addition of the "Spectroscopy Equipment and Accessories - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. This report analyzes the worldwide markets for Spectroscopy Equipment and Accessories in US$ Thousand by the following Product Segments: The report profiles 117 companies including many key and niche players such as: 1. OUTLOOK A Prelude Overview Current and Future Analysis Sustained Growth for Aftermarket Products and Services 2. MARKET OVERVIEW Government Funding and Research Activities Propel Molecular Spectroscopy Market Growing Preference for Handheld Instruments Infrared Spectroscopy - A Peek into Technology and Application Trends Raman Spectroscopy - A Review of Advanced Technologies and Applications Tip-enhanced Raman Spectroscopy (TERS) Surface-enhanced Raman Spectroscopy (SERS) Spatially Offset Raman Spectroscopy (SORS) Magnetic Photoacoustoic Raman (MPR) Raman Spectroscopy Emerges as Attractive Analytical Tool for Pharmaceutical Industry Fluorescence Spectroscopy - A Gold Standard Technology Atomic Spectroscopy - An Overview Mass Spectrometry: Technological Developments and Expanding End-Use Applications to Bolster Growth Review of Select MS Technologies The Way Ahead for FT-MS and Magnetic Sector MS Technologies Portability: A Major Driving Force for MS Systems Market Nanotube Coating to Enable Miniaturization in Mass Spectrometers High Prices of MS Systems Hold Down Sales Growth Purpose-Built Mass Spectrometers to Transform Personalized Medicine Leading End Users of Mass Spectrometry Devices A Peek into Regulatory and Competitive Landscape in MS Ion-Trap Mass Spectrometry Technology Losses Sheen Reduced Government Spending on Laboratory Testing Lack of Suitable Software and Diversity of MS Systems - A Major Challenge Smaller Clinical Laboratories Continue to Shy Away from Mass Spectrometers 3. MARKET TRENDS & ISSUES Rise in Drug Development Outsourcing to Fuel Global Spectroscopy Market Growing Significance of Miniaturization in Spectroscopy Shift of Analytical Instruments Industry to Mass Customization Improved Mobility Broadens the Role of Spectroscopy Improved Analyzer Reliability and Performance Hyphenated Technologies Exhibit Growth Spectroscopy Makes Inroads into Novel Applications Applications Extend to Defense and Civilian Areas Atomic and Molecular Spectrometers Benefit from Technological Improvements Demand for Used Spectroscopy Instruments to Grow Robustly in Future 4. COMPETITIVE LANDSCAPE Competition in the Spectrometry Market: An Insight Molecular Spectroscopy: A Highly Fragmented Market List of Leading Players in the Global Molecular Spectroscopy Market by Product Type Atomic Spectroscopy Market List of Leading Players in the Global Atomic Spectroscopy Market Mass Spectrometry Market List of Leading Players in the Global Mass Spectrometry Market 5. PRODUCT OVERVIEW Spectroscopy Spectrophotometer Fluorometer Different Types of Spectrophotometry Analysis Infrared Spectrophotometry Near-Infrared Spectrophotometry Visible Spectrophotometry Ion Mobility Spectrometry Color Spectrophotometry Near-Ultraviolet Spectrophotometry Spectrometry Spectrometers: A Broad Spectrum of Devices A. Molecular Spectroscopy - The Study of Absorption of Light by Molecules Ultraviolet/Visible (UV/VIS) Spectroscopy Raman Spectroscopy Nuclear Magnetic Resonance (NMR) Spectrometers Near Infrared (NIR) Spectroscopy Applications of Near-IR Techniques Process Analysis Applications of the NIR Spectroscopy Infrared Spectroscopy Fourier-Transform Infrared (FTIR) Spectroscopy B. Atomic Spectroscopy Arc/Spark Spectrometry ICP and ICP-MS Atomic Absorption Spectroscopy Atomic Absorption Analysis Instrumentation Atomizers Double Beam Systems Applications Trends and Future Developments X-Ray Fluorescence Spectrometers (XRF) C. Mass Spectrometry (MS) Mass Spectrometer Types of Mass Spectrometers and their Applications Liquid Chromatography-Mass Spectrometry (LC-MS) Gas Chromatography-Mass Spectrometry (GC-MS) MALDI-TOF Fluorescence Spectroscopy - An Overview Biomedical Applications of Fluorescence Spectroscopy Fluorescence Quenching Fluorescence Polarization Resonance Energy Transfer Filter Fluorimeters Spectrofluorimeters Monochromators Fluorescence-Lifetime Measurements 6. PRODUCT INNOVATIONS/INTRODUCTIONS Shimadzu Launches LCMS-8045 Mass Spectrometer in Europe JUKI Group Commercializes AY555 Spectrophotometer Avantes Launches AvaSpec-Hero Sensline Spectrometer Agilent Launches New 4210 Microwave Plasma-Atomic Emission Spectrometer Princeton Launches FERGIE Spectroscopy System Konica Minolta Introduces Automobile Specific Spectrophotometers, CM-25cG and CM-M6 Shimadzu Launches New GC-MS/MS System, GCMS-TQ8050 Datacolor Introduces Datacolor 20D for Paint Retailers StellarNet Launches Portable Research Grade Raman Spectroscopy System Jenway® Launches New Visible Scanning Spectrophotometer, 7200 IRsweep to Launch IRspectrometer Shimadzu Introduces Atomic Absorption Spectrophotometer, AA-6880F Bruker Launches timsTOF System Thermo Fisher Launches New Spectrometry Devices Techkon Launches Continuous Scanning Spectrophotometer, SpectroEdge ES7500 Sciex Introduces SCIEX QTRAP® 6500+ LC-MS/MS System StellarNet Launches RED-Wave-NIRX-SR Spectrometer Thermo Scientific Launches NanoDrop One Spectrophotometers Thermo Scientific Launches GENESYS 30 Visible-Range Spectrophotometer Thermo Scientific Launches New DXR2 Line of Raman Microscopes Bruker Launches Total Reflection X-Ray Fluorescence Spectrometer, S4 TStar Agilent Launches 5110 ICP-OES Magritek Introduces 60 MHz Benchtop NMR Spectrometers, Spinsolve 60 Thermo Scientific Launches New FT-NIR Spectrometer, Nicolet iS5N Rigaku Launches New Benchtop Variable Spot EDXRF Spectrometer, Rigaku NEX DE Advion Introduces TIDES EXPRESS Merck Introduces Spectroquant® Prove Spectrophotometers Shimadzu Introduces Inductively Coupled Plasma Mass Spectrometer, ICPMS-2030 AQULABO Group Introduces Uviline 9300 and Uviline 9600 Rigaku Launches Rigaku ZSX Primus IV StellarNet BLUE-Wave Compact Spectrometers Line SPECTRO Introduces New Line of SPECTRO XEPOS Spectrometers Thermo Fisher Introduces Thermo Scientific 253 Ultra HR-IRMS StellarNet Launches BLACK-Comet-HR Specac Introduces Pearl Liquid Analysis Accessory Agilent Introduces Agilent 5977B HES GC/MSD System in China Datacolor Introduces New Line of Color Measurement Spectrophotometers Bruker Introduces HH-LIBS Device, EOS 500 Bruker Launches 10 kHz rapifleX MALDI-TOF/TOF Mass Spectrometer Konica Minolta Introduces Auto-Scanning Spectrophotometer, FD-9 Rigaku Introduces Rigaku NANOHUNTER II TXRF Spectrometer SPECTRO Introduces New SPECTROLAB Arc/Spark Optical Emission Spectrometers SPECTRO Introduces SPECTROSCOUT X-ray Fluorescence Spectrometer Bruker Introduces S2 PUMA Shimadzu Introduces Shimadzu LCMS-8060 Triple Quadrupole Mass Spectrometer Thermo Scientific Launches Orbitrap Fusion Lumos Tribrid Mass Spectrometer Agilent Introduces Agilent 6470 Triple Quadrupole LC/MS Waters Introduces Vion IMS QTof Mass Spectrometer DeNovix Introduces DS-11 FX+ Spectrophotometer / Fluorometer Agilent Launches Agilent 6545 Q-TOF Mass Spectrometry System Implen Introduces Fourth Generation NanoPhotometer® Spectrophotometers Shimadzu Corporation Compact Monochromator System Package, SPG-120-REV JEOL Develops JPS-9030, X-ray Photoelectron Spectrometer Datacolor Introduces CHECK 3 Portable Spectrophotometer SPECTRO Launches SPECTRO xSort Handheld EDXRF Spectrometers Bruker Handheld Raman Spectrometer, BRAVO Shimadzu Launches RF-6000 Spectrofluorophotometer X-Rite Introduces X-Rite Ci7800 and X-Rite Ci7600 SPECTRO Introduces SPECTRO xSORT Line of Handheld EDXRF Spectrometers Analytik Jena Introduces New ICP-MS Products, PlasmaQuant® MS and PlasmaQuant® MS Elite Ocean Optics Introduces New Miniature Spectrometer, Flame Shimadzu Launches UV1280 UVVIS Spectrophotometer in the US SPECTRO Introduces SPECTRO ARCOS High-Resolution Spectrometer JEOL Launches JMS-T200GC High-end GC-TOFMS Thermo Scientific Launches Orbitrap Based Q Exactive Focus LC MS/MS Mass Spectrometer 7. RECENT INDUSTRY ACTIVITY Bruker Acquires Active Spectrum Inc. Wasatch Photonics Acquires Process Raman Spectroscopy Technology from Mustard Tree Instruments Shimadzu Institutes Shimadzu China Mass Spectrometry Center INSION Enters into Distribution Agreement with Digilab - The United States (75) - Canada (2) - Japan (11) - Europe (40) - France (3) - Germany (11) - The United Kingdom (18) - Italy (1) - Spain (1) - Rest of Europe (6) - Asia-Pacific (Excluding Japan) (9) - Middle East (1) For more information about this report visit http://www.researchandmarkets.com/research/gxbsmg/spectroscopy
News Article | November 25, 2016
Global Electrophoresis Systems Market Outlook 2016-2021 has been prepared based on the synthesis, analysis, and interpretation of information about the global Electrophoresis Systems market collected from specialized sources. Albany, NY, November 25, 2016 --( Request For Free Sample Report: http://www.marketresearchhub.com/enquiry.php?type=S&repid=808315 Initially, the report segments the market on the basis of types, applications and geographically segmented by above regions along with the production, consumption and import/export. Further, every segment is classified and analyzed on the basis of product types, application and the end-use industries of the global market. There are several methodical tools which are used in the research such as investment returns, feasibility and market effect factor analysis to present a comprehensive study of the market for electrophoresis system across the world. The report describes the electrophoresis system process in order to understand the whole concept. Electrophoresis systems are devices that are used to separate molecules based on their charge and size as they move through a solution under the influence of an electric field. There are several uses of an electrophoresis system such as: • It is used for both DNA and RNA analysis. • This is the most suitable technique used in laboratories in order to separate macromolecules. • It can be also used for qualitative or quantitative analysis of different materials, or material component analysis as well as single component extraction and preparation. Electrophoresis systems are purely based on the principle of design and manufacture. The report offers major statistics on the state of the industry which acts as a valuable source of guidance for readers and direction for companies who are interested in this market. The key leaders of the Electrophoresis system in the global market are mentioned below: • Analytik Jena • Cleaver Scientific • GE Healthcare Life Sciences • Agilent Technologies • Syngene • Labnet International • SCILOGEX • BIOTEC-FISCHER • CELL - Start Project • Auxilab S.L • BPC BioSed • Sage Science • Helena Biosciences • Bio-Rad • Sebia • SCIEX • UVP • VWR • Texas BioGene Read Full Report with TOC: http://www.marketresearchhub.com/report/global-electrophoresis-systems-market-research-report-2016-report.html The study also covers key technological developments in the coming years. Leading players mentioned along with their key strategies, manufacturing base and competitors list. Moreover, the competitive landscape section of the report provides a clear insight into the market share analysis of industry players. At the end, upstream raw materials, equipment’s and downstream demand analysis is also presented out in the report. About Market Research Hub: Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps. MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients. Contact Details: 90 State Street, Albany, NY 12207, United States Toll Free: 866-997-4948 (US-Canada) Tel: +1-518-621-2074 Email: email@example.com Website: http://www.marketresearchhub.com Albany, NY, November 25, 2016 --( PR.com )-- Market Research Hub has recently added a new report titled “Global Electrophoresis Systems Market Research Report 2016,” to its offerings. This research report is a professional and in-depth study on the current state of the electrophoresis system industry from 2011-2016. Additionally, it also provides extensive market forecasts from 2011 to 2021 by different regions. Key regions highlighted in the report are North America, Europe, China, Japan, Korea and Taiwan.Request For Free Sample Report: http://www.marketresearchhub.com/enquiry.php?type=S&repid=808315Initially, the report segments the market on the basis of types, applications and geographically segmented by above regions along with the production, consumption and import/export. Further, every segment is classified and analyzed on the basis of product types, application and the end-use industries of the global market. There are several methodical tools which are used in the research such as investment returns, feasibility and market effect factor analysis to present a comprehensive study of the market for electrophoresis system across the world.The report describes the electrophoresis system process in order to understand the whole concept. Electrophoresis systems are devices that are used to separate molecules based on their charge and size as they move through a solution under the influence of an electric field. There are several uses of an electrophoresis system such as:• It is used for both DNA and RNA analysis.• This is the most suitable technique used in laboratories in order to separate macromolecules.• It can be also used for qualitative or quantitative analysis of different materials, or material component analysis as well as single component extraction and preparation.Electrophoresis systems are purely based on the principle of design and manufacture. The report offers major statistics on the state of the industry which acts as a valuable source of guidance for readers and direction for companies who are interested in this market.The key leaders of the Electrophoresis system in the global market are mentioned below:• Analytik Jena• Cleaver Scientific• GE Healthcare Life Sciences• Agilent Technologies• Syngene• Labnet International• SCILOGEX• BIOTEC-FISCHER• CELL - Start Project• Auxilab S.L• BPC BioSed• Sage Science• Helena Biosciences• Bio-Rad• Sebia• SCIEX• UVP• VWR• Texas BioGeneRead Full Report with TOC: http://www.marketresearchhub.com/report/global-electrophoresis-systems-market-research-report-2016-report.htmlThe study also covers key technological developments in the coming years. Leading players mentioned along with their key strategies, manufacturing base and competitors list. Moreover, the competitive landscape section of the report provides a clear insight into the market share analysis of industry players. At the end, upstream raw materials, equipment’s and downstream demand analysis is also presented out in the report.About Market Research Hub:Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.Contact Details:90 State Street,Albany, NY 12207,United StatesToll Free: 866-997-4948 (US-Canada)Tel: +1-518-621-2074Email: firstname.lastname@example.orgWebsite: http://www.marketresearchhub.com Click here to view the list of recent Press Releases from Market Research Hub
News Article | February 15, 2017
REDONDO BEACH, CA--(Marketwired - Feb 9, 2017) - SECFilings.com, a leading financial news and information portal offering free real time public company filing alerts, announces an article discussing Pressure BioSciences Inc.'s ( : PBIO) recently announced CE Marking for the company's newest device, the Barocycler 2320EXT. The life sciences industry has rapidly evolved over the past decade. For example, newly developed proteomic and genomic analysis techniques have helped researchers improve the detection, treatment, and prevention of cancers and other serious diseases. New programs, such as the Cancer Moonshot Initiative, are designed to invest in these new technologies to accelerate the research and development of new treatment options for patients, as well as new preventive strategies. Pressure Bio's Pressure Cycling Technology improves upon the sample preparation process by subjecting cells to alternating cycles of hydrostatic pressure between ambient and high/ultra levels. This enables researchers to quickly, safely, and reproducibly control the cell lysis (breakage) process by effectively squeezing out important cellular components with minimal or no damage whatsoever -- like squeezing things out of a sponge. Pressure Bio recently launched the Barocycler 2320EXTREME -- the first major update of its flagship PCT-based sample preparation instrument in years. This release followed years of extensive user feedback. The compact, benchtop instrument offers many features and benefits not found in its predecessor, including data logging options, user-level security, computer-operated control with touch screen programming, and the ability to customize multiple pressure cycling parameters. These new features and benefits could greatly expand the universe of potential users worldwide. The company recently announced that it secured a CE Marking for the Barocycler 2320EXT -- a key milestone that enables it to sell the device throughout the entire European Economic Area, which includes 31 countries. Since 1985, the CE Mark has been required for products in 24 different categories sold within the European Economic Area, with each product falling under various directives that determine specific requirements designed to meet safety, health, and/or environmental requirements. Pressure Bio recently signed agreements with several distribution partners throughout Europe that could open the door to near-term revenue. In addition, the company is entering the second year of its co-marketing agreement with SCIEX -- a global provider of lab instrumentation with a large presence in Europe. Many key opinion leaders, like Professor Ruedi Aebersold, have also purchased the product, which has demonstrated its usefulness in advanced research operations. Please follow the link to read the full article: http://analysis.secfilings.com/articles/150-pressure-biosciences-ramps-up-commercialization-of-next-generation-instrument-with-ce-marking Founded in 2004, SECFilings.com provides free real time filing alerts to over 600,000 registered members and offers services to help public companies grow their audience of interested investors. Except for the historical information presented herein, matters discussed in this release contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC, which owns SECFilings.com, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. Emerging Growth LLC may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two. For full disclosure please visit: http://secfilings.com/Disclaimer.aspx.
News Article | November 11, 2016
MarketStudyReport.com adds “Global LC-MS Market by Manufacturers, Regions, Type and Application, Forecast to 2021” new report to its research database. The report spread across 116 pages with table and figures in it. Liquid chromatography?mass spectrometry (LC-MS, or alternatively HPLC-MS) is an analytical chemistry technique that combines the physical separation capabilities of liquid chromatography (or HPLC) with the mass analysis capabilities of mass spectrometry (MS). LC-MS is a powerful technique that has very high sensitivity, making it useful in many applications. Its application is oriented towards the separation, general detection and potential identification of chemicals of particular masses in the presence of other chemicals (i.e., in complex mixtures), e.g., natural products from natural-products extracts, and pure substances from mixtures of chemical intermediates. Preparative LC-MS systems can be used for rapid mass-directed purification of specific substances from such mixtures that are important in basic research, and pharmaceutical, agrochemical, food, and other industries. Browse full table of contents and data tables at https://www.marketstudyreport.com/reports/global-lc-ms-market-by-manufacturers-regions-type-and-application-forecast-to-2021/ Scope of the Report: This report focuses on the LC-MS in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Market Segment by Manufacturers, this report covers Thermo Fisher Scientific Waters Agilent Technologies Shimadzu PerkinElmer SCIEX Bruker Market Segment by Regions, regional analysis covers North America (USA, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, Korea, India and Southeast Asia) South America, Middle East and Africa Market Segment by Type, covers Single Quadrupole LC-MS Triple Quadrupole LC-MS Ion Trap LC-MS Market Segment by Applications, can be divided into Academic Pharma Food & Environment & Forensic There are 13 Chapters to deeply display the global LC-MS market. Chapter 1, to describe LC-MS Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the top manufacturers of LC-MS, with sales, revenue, and price of LC-MS, in 2015 and 2016; Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2015 and 2016; Chapter 4, to show the global market by regions, with sales, revenue and market share of LC-MS, for each region, from 2011 to 2016; Chapter 5, 6, 7 and 8, to analyze the key regions, with sales, revenue and market share by key countries in these regions; Chapter 9 and 10, to show the market by type and application, with sales market share and growth rate by type, application, from 2011 to 2016; Chapter 11, LC-MS market forecast, by regions, type and application, with sales and revenue, from 2016 to 2021; Chapter 12 and 13, to describe LC-MS sales channel, distributors, traders, dealers, appendix and data source. To receive personalized assistance write to us @ [email protected] with the report title in the subject line along with your questions or call us at +1 866-764-2150
News Article | February 22, 2017
Chemists at the University of Waterloo, SCIEX and Pfizer have discovered a new way to help the pharmaceutical industry identify and test new drugs, which could revolutionize drug development, and substantially reduce the cost and time drugs need to reach their market. The study, published in the journal ACS Central Science, outlines a technique called differential mobility spectrometry (DMS) which analyzes drug molecules based on their response to an electrical field and the condensation-evaporation cycles the drug experiences in that field via a process, known as microsolvation. "We can use this technique to measure drug properties in seconds to minutes with only nanograms of sample," says Scott Hopkins, a professor of chemistry at the University of Waterloo and corresponding author on the paper. "It's cost saving and high throughput, so you can test hundreds, even thousands of drugs quickly, increasing the rate of drug discovery." Currently drug candidates are put through a battery of tests to measure their chemical and physical properties, such as how easily the drug crosses cell membranes, to predict how it will behave in the human body. Drugs must perform within a specific range in order to move forward to clinical trials. Most drugs fail the initial stages resulting in lost time and money. "It takes time to grow cells and run replicate experiments to measure permeability," said Hopkins. "These kinds of assays are an arduous process, and the people that conduct this work are artists as well as scientists." In contrast, these essential physical and chemical properties can be extracted all at once with a single analysis using DMS. The technique is so sensitive it can differentiate between the same drug molecules with slightly different atomic structures - something traditional testing methods cannot do. "With this technology, the initial stages of drug development testing can be completed in hours rather than days," says Hopkins. "It's not only several orders of magnitude faster, it gives us information we never had access to before that we can use for rational drug design." Beyond improving the testing and design drugs go through, Hopkins is hopeful this technology will improve the success of candidate drugs being proposed in the first place by informing the design process.
News Article | March 1, 2017
Barocycler 2320EXTREME Honored as Superior Instrument for Sample Preparation by Leading Publication for CEOs, Top-tier Management, and Key Decision Makers Across North America SOUTH EASTON, MA--(Marketwired - Mar 1, 2017) - Pressure BioSciences, Inc. ( : PBIO) ("PBI" and the "Company"), a leader in the development and sale of broadly enabling, pressure cycling technology ("PCT")-based sample preparation solutions to the worldwide life sciences industry, today announced that its Barocycler 2320EXTREME ("2320EXT") has been named the "Best New Instrument for Sample Preparation 2017" by Corporate America News ("Corp America") as part of the publication's 2017 North American Excellence Awards. With a subscription list of more than 135,000 business and professional service providers, Corp America is a leading magazine in the U.S business market. The magazine's annual North American Excellence Awards honor companies and individuals who tirelessly work to drive innovation and exhibit true passion for their work. The award-winning, next-generation Barocycler 2320EXT is the latest addition to PBI's Barocycler family. It is a compact, bench-top instrument offering many advanced features and benefits. These and other additions have already positioned the Barocycler 2320EXT as an instrument of choice for life science key opinion leaders ("KOLs") worldwide, when preparing protein samples for analysis. Dr. Nate Lawrence, Vice President of Marketing and Sales for PBI, said: "We are honored to have been selected for this prestigious award. It was just eight months ago when we launched this next-generation Barocycler instrument, the 2320EXT. Since then, the instrument has been purchased by key scientists in academic, government, biotech and pharma labs worldwide, including institutions involved in the Cancer Moonshot Initiative. We believe this award affirms the significant potential of the Barocycler 2320EXT." ProCan, a cancer research initiative located in the Children's Medical Research Institute near Sydney Australia, and a Cancer Moonshot collaborator, purchased three Barocycler 2320EXTs in June 2016. At the time of their purchase, Professor Phil Robinson, co-head of ProCan, said: "Patient tumor samples can be pretty tiny and very heterogeneous, but the use of PCT in sample preparation allows researchers to analyze tissue samples as small as those provided by needle biopsies. So you can use incredibly small amounts of tissue, reliably digest them in a couple of hours, and get large amounts of information with the Barocycler 2320EXT." Professor Ruedi Aebersold, a world-renowned protein chemist who recently upgraded to the Barocycler 2320EXT, emphasized the importance of sample preparation in the article. Dr. Aebersold said: "Not only do we need to consider the method of analyzing the proteome, but we must also recognize that the method of sample preparation used to optimize protein extraction & digestion is equally as important." Dr. Lawrence commented: "It is the support of KOLs like Professors Robinson and Aebersold that we believe helped convince the panel of judges that the Barocycler 2320EXT deserved to win the 2017 North American Excellence Award for Best New Sample Preparation Instrument." PBI President and CEO Richard T. Schumacher was interviewed by the magazine upon selection of the award. In a four-page article, Mr. Schumacher provided an in-depth overview of PBI's patented PCT technology and its unique advantages, the Company's history of innovation and growth, its large market opportunity, additional features and benefits of the 2320EXT, the recent co-marketing agreement with global life sciences leader SCIEX, and his expectations that significant growth is on the horizon. To view the full article, visit http://www.corporateamericanews.com/2017-north-american-excellence-awards. A picture of the award-winning 2320EXT is on the inside front cover of the magazine and the article starts on page 8. About Pressure BioSciences, Inc. Pressure BioSciences, Inc. ("PBI") ( : PBIO) develops, markets, and sells proprietary laboratory instrumentation and associated consumables to the estimated $6 billion life sciences sample preparation market. Our products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or PCT) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions. To date, we have installed over 250 PCT systems in approximately 160 sites worldwide. There are over 100 publications citing the advantages of the PCT platform over competitive methods, many from key opinion leaders. Our primary application development and sales efforts are in the biomarker discovery and forensics areas. Customers also use our products in other areas, such as drug discovery & design, bio-therapeutics characterization, soil & plant biology, vaccine development, histology, and forensic applications. Forward Looking Statements Statements contained in this press release regarding PBI's intentions, hopes, beliefs, expectations, or predictions of the future are "forward-looking'' statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based upon the Company's current expectations, forecasts, and assumptions that are subject to risks, uncertainties, and other factors that could cause actual outcomes and results to differ materially from those indicated by these forward-looking statements. These risks, uncertainties, and other factors include, but are not limited to, the risks and uncertainties discussed under the heading "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2015, and other reports filed by the Company from time to time with the SEC. The Company undertakes no obligation to update any of the information included in this release, except as otherwise required by law. For more information about PBI and this press release, please click on the following website link: http://www.pressurebiosciences.com Please visit us on Facebook, LinkedIn, and Twitter
News Article | October 27, 2016
FRAMINGHAM, Mass.--(BUSINESS WIRE)--SCIEX, a global leader in life science analytical technologies, today announced an exciting application leveraging SCIEX LC-MS instruments and chemistries.